- By James Kravitz
- (General Dispatch) – The UK is going through a difficult time with shortages in the supply of coronavirus vaccines, especially for the population under 50 years of age, whose vaccines are in the testing and approval period.
- This important development could prolong the start of vaccine delivery to the nation’s younger population, who are also prone to infection.
- Matt Hancock, Secretary of Health, announced that 1.7 million doses of vaccine were ready to be shipped when he was interrupted by an unexpected order requiring further testing.
- It is explained that the decision was taken by the National Health Service when it made the evaluation of the proportionality of vaccines, determining that they would be insufficient, taking as a priority the most vulnerable adult population.
- It should be noted that the news devastated the hopes of physicians and other health personnel, knowing that they cannot fight the coronavirus in the short term.
- Despite the current limitations, the government expects to meet the objectives and deliver the first batch of doses to be supplied.
- For its part, the Medicines and Healthcare products Regulatory Agency recommended using the AstraZeneca vaccine, which is being accused of forming blood clots in the body.
- Certainly, UK citizens and healthcare workers should continue to wait for the supply of covid-19 vaccines and continue to take biosecurity measures.
Adittional Information:
Breitbart: UK faces vaccine shortfall, could delay shots for under 50s
AP News: UK faces vaccine shortfall, could delay shots for under 50s
